Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes Journal:Rheumatology and Immunology Research | 1-Mar-2022 | ||
Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome Journal:Cellular and Molecular Immunology | 2017 | ||
TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus Journal:Annals of the Rheumatic Diseases | 2018 |